Search

Your search keyword '"Rabaté C"' showing total 3 results
Start Over Author "Rabaté C" Publication Year Range Last 3 years
3 results on '"Rabaté C"'

1. One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals

Author

Hartmann, C., Kazhalawi, A., Lambert-Bordes, S., Bleunven, S., Bedos, J.-P., Greder-Belan, A., Rigaudea, S., Lecuyer, H., Jousset, A., Lebeaux, D., Levy, B., Rabate, C., Collignon, A., Batah, J., Francois, V., Sebbane, G., Woerther, P.-L., Loggia, G., Michon, J., Verdon, R., Samba, D., Méar, J.-B., Guillard, T., Nguyen, Y., Banisadr, F., Delmer, A., Himberlin, C., Diallo, S., Furet, I., Achouri, B., Reksa, A., Jouveshomme, S., Menage, E., Philippart, F., Hadj-Abdeslam, M., Durand-Gasselin, B., Eveillard, M., Kouatchet, A., Schmidt, A., Salanoubat, C., Heurtaux, M.-N., Cronier, P., Foufa, A., Le Monnier, A., Candela, T., Mizrahi, A., Bille, E., Bourgeois-Nicolaos, N., Cattoir, V., Farfour, E., Grall, I., Lecointe, D., Limelette, A., Marcade, G., Poilane, I., Poupy, P., Kansau, I., Zahar, J-R., and Pilmis, B.

Published
2022
Full Text
View/download PDF

2. The Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19: an ERACODA analysis

Author

Bouwmans, P., Brandts, L., Hilbrands, L.B., Duivenvoorden, R., Vart, P., Franssen, C.F., Covic, A., Islam, M., Rabaté, C., Jager, K.J., Noordzij, M., Gansevoort, R.T., Hemmelder, M.H., Bouwmans, P., Brandts, L., Hilbrands, L.B., Duivenvoorden, R., Vart, P., Franssen, C.F., Covic, A., Islam, M., Rabaté, C., Jager, K.J., Noordzij, M., Gansevoort, R.T., and Hemmelder, M.H.

Abstract

Item does not contain fulltext, BACKGROUND: Several guidelines recommend using the Clinical Frailty Scale (CFS) for triage of critically ill coronavirus disease 2019 (COVID-19) patients. This study evaluates the impact of CFS on intensive care unit (ICU) admission rate and hospital and ICU mortality rates in hospitalized dialysis patients with COVID-19. METHODS: We analysed data of dialysis patients diagnosed with COVID-19 from the European Renal Association COVID-19 Database. The primary outcome was ICU admission rate and secondary outcomes were hospital and ICU mortality until 3 months after COVID-19 diagnosis. Cox regression analyses were performed to assess associations between CFS and outcomes. RESULTS: A total of 1501 dialysis patients were hospitalized due to COVID-19, of whom 219 (15%) were admitted to an ICU. The ICU admission rate was lowest (5%) in patients >75 years of age with a CFS of 7-9 and highest (27%) in patients 65-75 years of age with a CFS of 5. A CFS of 7-9 was associated with a lower ICU admission rate than a CFS of 1-3 [relative risk 0.49 (95% confidence interval 0.27-0.87)]. Overall, mortality at 3 months was 34% in hospitalized patients, 65% in ICU-admitted patients and highest in patients >75 years of age with a CFS of 7-9 (69%). Only 9% of patients with a CFS ≥6 survived after ICU admission. After adjustment for age and sex, each CFS category ≥4 was associated with higher hospital and ICU mortality compared with a CFS of 1-3. CONCLUSIONS: Frail dialysis patients with COVID-19 were less frequently admitted to the ICU. Large differences in mortality rates between fit and frail patients suggest that the CFS may be a useful complementary triage tool for ICU admission in dialysis patients with COVID-19.

Published
2022

3. The Clinical Frailty Scale as a triage tool for ICU admission of dialysis patients with COVID-19: an ERACODA analysis.

Author

Bouwmans P, Brandts L, Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Covic A, Islam M, Rabaté C, Jager KJ, Noordzij M, Gansevoort RT, and Hemmelder MH

Subjects
Humans, Aged, Triage, COVID-19 Testing, Renal Dialysis, Intensive Care Units, Frailty diagnosis, Frailty epidemiology, COVID-19 diagnosis
Abstract

Background: Several guidelines recommend using the Clinical Frailty Scale (CFS) for triage of critically ill coronavirus disease 2019 (COVID-19) patients. This study evaluates the impact of CFS on intensive care unit (ICU) admission rate and hospital and ICU mortality rates in hospitalized dialysis patients with COVID-19., Methods: We analysed data of dialysis patients diagnosed with COVID-19 from the European Renal Association COVID-19 Database. The primary outcome was ICU admission rate and secondary outcomes were hospital and ICU mortality until 3 months after COVID-19 diagnosis. Cox regression analyses were performed to assess associations between CFS and outcomes., Results: A total of 1501 dialysis patients were hospitalized due to COVID-19, of whom 219 (15%) were admitted to an ICU. The ICU admission rate was lowest (5%) in patients >75 years of age with a CFS of 7-9 and highest (27%) in patients 65-75 years of age with a CFS of 5. A CFS of 7-9 was associated with a lower ICU admission rate than a CFS of 1-3 [relative risk 0.49 (95% confidence interval 0.27-0.87)]. Overall, mortality at 3 months was 34% in hospitalized patients, 65% in ICU-admitted patients and highest in patients >75 years of age with a CFS of 7-9 (69%). Only 9% of patients with a CFS ≥6 survived after ICU admission. After adjustment for age and sex, each CFS category ≥4 was associated with higher hospital and ICU mortality compared with a CFS of 1-3., Conclusions: Frail dialysis patients with COVID-19 were less frequently admitted to the ICU. Large differences in mortality rates between fit and frail patients suggest that the CFS may be a useful complementary triage tool for ICU admission in dialysis patients with COVID-19., (© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results